DERIVED FROM ESPIROOXATIOLANO-QUINUCLIDINA FOR THE TREATMENT OF XEROSTOMY.

摘要

A THERAPEUTIC AGENT IS PRESENTED FOR THE TREATMENT OF SEROSTOMY THAT INCLUDES A DERIVATIVE OF SPYROOXATIOLANOQUINUCLIDINE OR AN ADDITIONED SALT OF THE SAME AS ACTIVE INGREDIENT, REPRESENTED BY FORMULA (I) (IN WHICH R {SUP, 1} AND , 2} MAY BE EQUAL OR DIFFERENT AND EACH REPRESENTATIVE HYDROGEN, RENT, CYCLOPENTIL, CYCLHEXIL, ARIL, DIARILMETILOL, OR RENT THAT MAY BE REPLACED BY ONE OR MORE GROUPS). THE PREVIOUS THERAPEUTIC AGENT CAN BE ORALLY OR PARENTERALLY ADMINISTERED AND CURE SEROSTOMY. SPECIFICALLY THE AGENT CAN BE USED TO IMPROVE AND / OR CURE THE DRY MOUTH CAUSED BY VARIOUS DISEASES WITH ORGANIC CHANGES IN THE SALIVAL GLANDS, INJURIES IN THE SALIVAL GLANDS, ACCOMPANIED WITH SYSTEMS DISEASES, NECROSASASASASAS LASAS CELLULASES BY CELLULASES HIV (AIDS), HYPOFUNCTION OF THE SECTION OF THE SALIVA, AFFECTION OF DIFFERENT MEDICINES THAT HAVE BEEN TAKEN, AND ALSO MENTAL FATIGUE OR BAD CONDITIONS DUE TO COMPLEX SOCIAL LIFE SITUATIONS.